| ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal … Endorsed by: the European Stroke Organisation (ESO), ... European heart journal 32 (22), 2851-2906, 2011 | 1652 | 2011 |
| Plasma viscosity: a forgotten variable G Késmárky, P Kenyeres, M Rábai, K Tóth Clinical hemorheology and microcirculation 39 (1-4), 243-246, 2008 | 410 | 2008 |
| In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine B Horvath, Z Marton, R Halmosi, T Alexy, L Szapary, J Vekasi, Z Biro, ... Clinical neuropharmacology 25 (1), 37-42, 2002 | 149 | 2002 |
| Platelet aggregometry testing: molecular mechanisms, techniques and clinical implications K Koltai, G Kesmarky, G Feher, A Tibold, K Toth International journal of molecular sciences 18 (8), 1803, 2017 | 144 | 2017 |
| Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases B Horvath, D Hegedus, L Szapary, Z Marton, T Alexy, K Koltai, L Czopf, ... Experimental & Clinical Cardiology 9 (1), 31, 2004 | 135 | 2004 |
| Clinical importance of aspirin and clopidogrel resistance G Feher, A Feher, G Pusch, K Koltai, A Tibold, B Gasztonyi, E Papp, ... World journal of cardiology 2 (7), 171, 2010 | 128 | 2010 |
| Clopidogrel resistance: role of body mass and concomitant medications G Feher, K Koltai, B Alkonyi, E Papp, Z Keszthelyi, G Kesmarky, K Toth International journal of cardiology 120 (2), 188-192, 2007 | 124 | 2007 |
| Hemorheological parameters in coronary artery disease G Kesmarky, K Toth, L Habon, G Vajda, I Juricskay Clinical hemorheology and microcirculation 18 (4), 245-251, 1998 | 115 | 1998 |
| Hemorheological disturbances in patients with chronic cerebrovascular diseases L Szapary, B Horvath, Z Marton, T Alexy, N Demeter, M Szots, A Klabuzai, ... Clinical hemorheology and microcirculation 31 (1), 1-9, 2004 | 107 | 2004 |
| Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods Z Marton, G Kesmarky, J Vekasi, A Cser, R Russai, B Horvath, K Toth Clinical hemorheology and microcirculation 24 (2), 75-83, 2001 | 80 | 2001 |
| Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and … L Szapary, B Horvath, Z Marton, T Alexy, G Kesmarky, T Habon, M Szots, ... CNS drugs 18, 165-172, 2004 | 70 | 2004 |
| Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables G Feher, K Koltai, E Papp, B Alkonyi, A Solyom, P Kenyeres, G Kesmarky, ... Drugs & aging 23, 559-567, 2006 | 69 | 2006 |
| Hemorheological alterations in patients with diabetic retinopathy J Vekasi, ZS Marton, G Kesmarky, A Cser, R Russai, B Horvath Clinical hemorheology and microcirculation 24 (1), 59-64, 2001 | 68 | 2001 |
| Thrombosis preventive potential of chicory coffee consumption: a clinical study E Schumacher, É Vigh, V Molnár, P Kenyeres, G Fehér, G Késmárky, ... Phytotherapy Research 25 (5), 744-748, 2011 | 67 | 2011 |
| The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals T Habon, E Szabados, G Kesmarky, R Halmosi, T Past, B Sumegi, K Toth Cardiovascular research 52 (1), 153-160, 2001 | 58 | 2001 |
| Viscosity, hemostasis and inflammation in atherosclerotic heart diseases G Késmárky, G Fehér, K Koltai, B Horváth, K Tóth Clinical hemorheology and microcirculation 35 (1-2), 67-73, 2006 | 54 | 2006 |
| Hemorheological parameters and aging G Feher, K Koltai, G Kesmarky, L Szapary, I Juricskay, K Toth Clinical hemorheology and microcirculation 35 (1-2), 89-98, 2006 | 53 | 2006 |
| Follow‐up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes Z Marton, B Horvath, T Alexy, G Kesmarky, ZS Gyevnar, L Czopf, T Habon, ... Clinical hemorheology and microcirculation 29 (2), 81-94, 2003 | 53 | 2003 |
| Erythrocyte transport efficacy of human blood: a rheological point of view L Bogar, I Juricskay, G Kesmarky, P Kenyeres, K Toth European journal of clinical investigation 35 (11), 687-690, 2005 | 48 | 2005 |
| Scavenger effect of experimental and clinically used cardiovascular drugs Z Marton, R Halmosi, B Horvath, T Alexy, G Kesmarky, J Vekasi, I Battyany, ... Journal of cardiovascular pharmacology 38 (5), 745-753, 2001 | 47 | 2001 |
